Companies: 10,795·Total market cap: $144.5T
Merck & Co., Inc.

Merck & Co., Inc.

MRKNYSEHealthcare● Active
$120.79
+$0.53(+0.44%)
Market Cap$298.3B
P/E Ratio
52W High$125.14
52W Low$76.66

Merck & Co., Inc. (MRK) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

mrk · stock forecast · 37 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 37 Wall Street analysts in the past 3 months

SellBuy

Buy

37 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
25
Hold
11
Sell
1
Strong Sell
0
Total: 37 · Buy rate: 67.6%

12-Month Price Target

High

$150

Consensus

$131

+8.2% upside

Low

$100

Median: $135 · Last Close: $120.79

The Merck & Co., Inc. (MRK) analyst consensus is Buy, based on ratings from 37 Wall Street analysts over the past 3 months. The average 12-month MRK price target is $130.69, representing +8.2% upside from the current price of $120.79.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $131 (8.2%)

Consensus Target

$130.69

8.2% upside

High Target

$150

24.2%

Low Target

$100

-17.2%

Current Price

$120.79

as of today

Based on analyst price targets, the MRK stock price prediction for the next 12 months ranges from $100 to $150. The consensus MRK price forecast of $130.69 implies 8.2% upside from the current price of $120.79.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$121.640.71%

1-day model range: $121.23–$122.06. Peak: $122.06 (+0.71%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$128+6.3%
2028$134+10.6%
2029$137+13.5%
2030$139+15.5%
2031+16.8%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)66.0Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · MRK · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$117.31BUY
MA 10$118.76BUY
MA 20$115.83BUY
MA 50$116.18BUY
MA 100$116.12BUY
MA 200$103.93BUY
Current $MRK · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$118.65BUY
EMA 10$117.80BUY
EMA 20$116.68BUY
EMA 50$115.80BUY
EMA 100$113.25BUY
EMA 200$107.40BUY
Current $MRK · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Wells Fargo2026-05-01
Maintains
OverweightOverweight
UBS2026-04-13
Maintains
BuyBuy
JP Morgan2026-04-06
Maintains
OverweightOverweight
RBC Capital2026-03-30
Maintains
OutperformOutperform
Citigroup2026-03-20
Maintains
NeutralNeutral
Wells Fargo2026-03-12
Maintains
OverweightOverweight
Freedom Broker2026-02-09
Maintains
HoldHold
Guggenheim2026-02-06
Maintains
BuyBuy
Cantor Fitzgerald2026-02-04
Maintains
NeutralNeutral
Citigroup2026-02-04
Maintains
NeutralNeutral

Wall Street analysts have recently issued updated ratings on Merck & Co., Inc. (MRK) stock. Of the recent 326 rating actions, 42 were upgrades and 31 were downgrades. 37 analysts currently cover MRK.

Analyst Recommendation Trends

Buy ratings413
Hold ratings101
Sell ratings00

MRK analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$66.7B

↓ 10.9% YoY

Revenue Next Year

$70.2B

↑ 5.2% YoY

EPS This Year

$5.14

EPS Next Year

$9.64

↑ 87.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast MRK EPS of $5.14 for the current fiscal year, based on estimates from 5 analysts. The MRK revenue forecast is $66.7B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The MRK stock forecast is supported by two independent data sources: analyst consensus ratings from 37 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MRK price target is $130.69 (+8.2% upside), with an analyst consensus of Buy.

The MRK short-term stock prediction for tomorrow is $121.64 (+0.71%). The MRK stock price prediction for 2027 estimates an average of $128. The MRK stock prediction for 2030 projects a range of $134–$145.

Merck & Co., Inc. trades on NYSE under the ticker MRK. The MRK stock outlook for 2027 is broadly positive, supported by a Buy consensus among 68% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

MRK forecast · 8 questions

According to 37 Wall Street analysts, the average 12-month MRK price target is $130.69, with a high forecast of $150.00 and a low of $100.00. The median price target is shown in the chart above when available. This implies +8.2% potential upside from the current price of $120.79.

MRK price targetWhat is MRK price targetMRK analyst price targetMRK 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.